640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer

• Gady Cojocaru,
• Inbal Barbiro,
• Manish Patel,
• Manish Sharma,
• Dale Shepard,
• Drew Rasco,
• Bartosz Chmielowski,
• Kyriakos P Papadopoulos,
• Eran Ophir,
• Ecaterina Dumbrava,
• Erika Hamilton,
• Pierre Ferre,
• Daniel Vaena,
• Judy S Wang,
• Adeboye H Adewoye

Affiliations

Gady Cojocaru

Compugen Ltd., Holon, Israel

Inbal Barbiro

Aff1 grid.418916.30000 0004 0506 4804Compugen Ltd. Israel

Manish Patel

13Florida Cancer Specialists, Sarasota, FL, USA

Manish Sharma

3START Midwest, Grand Rapids, MI, USA

Dale Shepard

Aff319 grid.239578.20000000106754725Cleveland Clinic Cleveland OH USA

Drew Rasco

2The START Center for Cancer Care, San Antonio, TX, USA

Bartosz Chmielowski

7University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA

Kyriakos P Papadopoulos

Aff1 grid.477989.c0000000404347503South Texas Accelerated Research Therapeutics (START) San Antonio TX USA

Eran Ophir

Aff38 grid.418916.30000000405064804Compugen Ltd Holon Israel

Ecaterina Dumbrava

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Erika Hamilton

Sara Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA

Pierre Ferre

3Pierre Fabre Research Institute, Toulouse, France

Daniel Vaena

6West Cancer Center and Rsrch Institute., Memphis, TN, USA

Judy S Wang

9Florida Cancer Specialists/SCRI, Sarasota, FL, USA

Adeboye H Adewoye

12Compugen USA Inc., San Francisco, CA, USA